Niels V. Krarup
Bagsvaerd, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
GLP-1 and MASH: When weight loss isn't the whole story.
Journal: Cell metabolism
Published: June 01, 2026
Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH.
Journal: Alimentary pharmacology & therapeutics
Published: March 03, 2025
Liver fibrosis is associated with clinical and economic burden of cardiovascular disease in MASH.
Journal: JHEP reports : innovation in hepatology
Published: October 09, 2024
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis.
Journal: Hepatology (Baltimore, Md.)
Published: June 28, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 26, 2023
A comparison of pediatric basic life support self-led and instructor-led training among nurses.
Journal: European journal of emergency medicine : official journal of the European Society for Emergency Medicine
Published: July 17, 2015
Lower reoperation rate for cemented femoral stem than for uncemented femoral stem in primary total hip arthroplasty following a displaced femoral neck fracture.
Journal: SICOT-J
Published: January 01, 2015
The dislocating hip replacement - revision with a dual mobility cup in 56 consecutive patients.
Journal: The open orthopaedics journal
Published: April 30, 2014
Dual mobility cup reduces dislocation and re-operation when used to treat displaced femoral neck fractures.
Journal: International orthopaedics
Published: October 21, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026